Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Daniel Willis
Invoxia seeks animal health expertise for development of GPS pet tracker
French telecommunications specialist Invoxia is taking its expertise in the human GPS space into the companion animal market.
Amlan names new sales director for Asia Pacific region
Amlan International has appointed Clare Mari Torralba to the role of regional sales director for the Asia Pacific region.
Roslin study to investigate influenza A species spread
A new study by The Roslin Institute aims to identify genes that are vital in reducing infection of influenza A virus in pigs and chickens.
Veramaris research reveals importance of omega-3 to salmon industry
Research from Veramaris has revealed a strong connection between omega-3 eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) content in salmon, and increased salmon consumption frequency among US consumers.
Swedish pet product firm establishes Spanish subsidiary
Malmo-based Swedencare has opened a sales and marketing subsidiary based in Barcelona.
Ark accelerates second canine therapeutic development, eyes potential spin-out
California-based Ark Animal Health began work on establishing a companion animal therapeutics portfolio in 2014. After five years, the company is readying the launch of its resiniferatoxin candidate. Animal Pharm analyst Daniel Willis spoke to Ark president Alexis Nahama at the recent Animal Health Investment Europe forum in London about the company's future plans.